Lenti-GDNF Gene Therapy Protects Against Alzheimer's Disease-Like Neuropathology in 3xTg-AD Mice and MC65 Cells

Susana Revilla et al.

Detalles Bibliográficos
Autores: Revilla, Susana, Álvarez-López, María Jesús, Perpiñá, Unai, García-Mesa, Yoelvis, Bortolozzi, Analía, Kaliman, Perla, Cristòfol, Rosa, Sanfeliu, Coral
Tipo de recurso: artículo
Estado:Versión aceptada para publicación
Fecha de publicación:2014
País:España
Institución:Consejo Superior de Investigaciones Científicas (CSIC)
Repositorio:DIGITAL.CSIC. Repositorio Institucional del CSIC
OAI Identifier:oai:digital.csic.es:10261/124948
Acceso en línea:http://hdl.handle.net/10261/124948
Access Level:acceso abierto
Palabra clave:Alzheimer disease
Gene therapy
Glial cell line-derived neurotrophic factor
Neuroblastoma
Transgenic mice
id ES_d01b2c46daa08ac3fd7b88c0ea8bc4e4
oai_identifier_str oai:digital.csic.es:10261/124948
network_acronym_str ES
network_name_str España
spelling Lenti-GDNF Gene Therapy Protects Against Alzheimer's Disease-Like Neuropathology in 3xTg-AD Mice and MC65 Cells Revilla, Susana Álvarez-López, María Jesús Perpiñá, Unai García-Mesa, Yoelvis Bortolozzi, Analía Kaliman, Perla Cristòfol, Rosa Sanfeliu, Coral Alzheimer disease Gene therapy Glial cell line-derived neurotrophic factor Neuroblastoma Transgenic mice Susana Revilla et al. © 2014 John Wiley & Sons Ltd. Summary: Aims: Glial cell-derived neurotrophic factor (GDNF) is emerging as a potent neurotrophic factor with therapeutic potential against a range of neurodegenerative conditions including Alzheimer's disease (AD). We assayed the effects of GDNF treatment in AD experimental models through gene-therapy procedures. Methods: Recombinant lentiviral vectors were used to overexpress GDNF gene in hippocampal astrocytes of 3xTg-AD mice in vivo, and also in the MC65 human neuroblastoma that conditionally overexpresses the 99-residue carboxyl-terminal (C99) fragment of the amyloid precursor protein. Results: After 6 months of overexpressing GDNF, 10-month-old 3xTg-AD mice showed preserved learning and memory, while their counterparts transduced with a green fluorescent protein vector showed cognitive loss. GDNF therapy did not significantly reduce amyloid and tau pathology, but rather, induced a potent upregulation of brain-derived neurotrophic factor that may act in concert with GDNF to protect neurons from atrophy and degeneration. MC65 cells overexpressing GDNF showed an abolishment of oxidative stress and cell death that was at least partially mediated by a reduced presence of intracellular C99 and derived amyloid β oligomers. Conclusions: GDNF induced neuroprotection in the AD experimental models used. Lentiviral vectors engineered to overexpress GDNF showed to be safe and effective, both as a potential gene therapy and as a tool to uncover the mechanisms of GDNF neuroprotection, including cross talk between astrocytes and neurons in the injured brain. Spanish MINECO. Grant Numbers: SAF2009-13093, SAF2012-39852, CSD2010-45; Generalitat. Grant Number: 2009/SGR/214; Fundació La Marató de TV3. Grant Number: 062931; European Regional Development Fund (ERDF) Peer Reviewed Wiley-Blackwell http://hdl.handle.net/10261/124948
title Lenti-GDNF Gene Therapy Protects Against Alzheimer's Disease-Like Neuropathology in 3xTg-AD Mice and MC65 Cells
spellingShingle Lenti-GDNF Gene Therapy Protects Against Alzheimer's Disease-Like Neuropathology in 3xTg-AD Mice and MC65 Cells
Revilla, Susana
Alzheimer disease
Gene therapy
Glial cell line-derived neurotrophic factor
Neuroblastoma
Transgenic mice
title_short Lenti-GDNF Gene Therapy Protects Against Alzheimer's Disease-Like Neuropathology in 3xTg-AD Mice and MC65 Cells
title_full Lenti-GDNF Gene Therapy Protects Against Alzheimer's Disease-Like Neuropathology in 3xTg-AD Mice and MC65 Cells
title_fullStr Lenti-GDNF Gene Therapy Protects Against Alzheimer's Disease-Like Neuropathology in 3xTg-AD Mice and MC65 Cells
title_full_unstemmed Lenti-GDNF Gene Therapy Protects Against Alzheimer's Disease-Like Neuropathology in 3xTg-AD Mice and MC65 Cells
title_sort Lenti-GDNF Gene Therapy Protects Against Alzheimer's Disease-Like Neuropathology in 3xTg-AD Mice and MC65 Cells
author Revilla, Susana
author_facet Revilla, Susana
Álvarez-López, María Jesús
Perpiñá, Unai
García-Mesa, Yoelvis
Bortolozzi, Analía
Kaliman, Perla
Cristòfol, Rosa
Sanfeliu, Coral
author_role author
author2 Álvarez-López, María Jesús
Perpiñá, Unai
García-Mesa, Yoelvis
Bortolozzi, Analía
Kaliman, Perla
Cristòfol, Rosa
Sanfeliu, Coral
author2_role author
author
author
author
author
author
author
topic Alzheimer disease
Gene therapy
Glial cell line-derived neurotrophic factor
Neuroblastoma
Transgenic mice
topic_facet Alzheimer disease
Gene therapy
Glial cell line-derived neurotrophic factor
Neuroblastoma
Transgenic mice
description Susana Revilla et al.
publishDate 2014
format article
status_str acceptedVersion
url http://hdl.handle.net/10261/124948
eu_rights_str_mv openAccess
publisher Wiley-Blackwell
institution Consejo Superior de Investigaciones Científicas (CSIC)
collection DIGITAL.CSIC. Repositorio Institucional del CSIC
reponame_str DIGITAL.CSIC. Repositorio Institucional del CSIC
instname_str Consejo Superior de Investigaciones Científicas (CSIC)
_version_ 1878441040386457600
publishDateSort 2014
author_browse Bortolozzi, Analía
Cristòfol, Rosa
García-Mesa, Yoelvis
Kaliman, Perla
Perpiñá, Unai
Revilla, Susana
Sanfeliu, Coral
Álvarez-López, María Jesús
publisherStr Wiley-Blackwell
score 6.9303427